Australians living with Type 1 Diabetes can access subsidised Dexcom G6. Learn more
Our products
t:slim X2™ Insulin Pump with Control-IQ™ Technology
The pump that gets updated, not outdated. The simple-to-use t:slim X2 insulin pump has a slim and sleek design and packed with big features.
Dexcom Continuous Glucose Monitoring Systems
Easy, accurate† and better health outcomes.1-5 Manage your diabetes with zero fingerpricks.‡ Stay on track to be your best with Dexcom G7 and Dexcom ONE+.
Dexcom Clarity
Gives Dexcom users quick access to important insights that help in the assessment of health: highs, lows, estimated HbA1C, average glucose reading, risk for hypoglycaemia and more.
Our Warrior Community
With over 20,000 Dexcom Warriors globally, Warriors are Dexcom CGM customers with inspiring stories who want to share their experiences with others – whether that be balancing their glucose levels whilst working the 9 to 5, competing in their chosen sport/profession at an elite level or perhaps progressing with their goals such as completing university degrees or adventurous treks. This program is supported by AMSL Diabetes.
Our Events
Our aim is to provide our customers and healthcare professionals with the best products and support. That’s why we’re always hosting events across the country. Whether you want to find out more about our products, get some great tips on diabetes management or just meet some great people, we have an event for you.
References and Important Risk Information
Dexcom is a continuous glucose monitoring system indicated for the management of (type 1, type 2, gestational) diabetes in people age 2 years and older where self-monitoring of blood glucose (SMBG) is indicated.
The t:slim X2 insulin pump is portable insulin infusion pump, including sterile cartridge, that delivers insulin subcutaneously through a disposable infusion set. The Tandem t:slim Mobile App is an accessory intended for use as a connected software device that is able to reliably and securely communicate with compatible insulin pumps.
‡ If your glucose alerts and readings from the Dexcom G7 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions; * This product is indicated for persons with diabetes mellitus age 2 years and older where self-monitoring of blood glucose (SMBG) is indicated; † As compared to Dexcom G6 System; || Smart device sold separately. To view a list of compatible devices, visit amsldiabetes.com.au/mobile-compatibility.
References: 1 Beck RW, et al. JAMA. 2017;317(4):371-378; 2 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374; 3 Martens T, et al. JAMA. 2021;325(22):2262-2272; 4 Laffel LM, et al. JAMA. 2020;323(23):2388-2396; 5 Welsh JB, et al. J Diabetes Sci Technol. 2024;18(1):143-7.
© 2025 Tandem Diabetes Care, Inc. All rights reserved. Tandem Diabetes Care, Basal-IQ, Control-IQ, and t:slim X2 are registered trademarks or trademarks of Tandem Diabetes Care, Inc., in the United States and other countries. ©2025 Dexcom, Inc. All rights reserved. Dexcom, Dexcom G6, Dexcom G7, Dexcom ONE+ are registered trademarks of Dexcom, Inc. in the United States and other countries. Australasian Medical and Scientific Limited is a Dexcom company.
MAT-6989
Dexcom is a continuous glucose monitoring system indicated for the management of (type 1, type 2, gestational) diabetes in people age 2 years and older where self-monitoring of blood glucose (SMBG) is indicated.
The t:slim X2 insulin pump is portable insulin infusion pump, including sterile cartridge, that delivers insulin subcutaneously through a disposable infusion set.
‡ If your glucose alerts and readings from the Dexcom G7 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions; * This product is indicated for persons with diabetes mellitus age 2 years and older where self-monitoring of blood glucose (SMBG) is indicated; † As compared to Dexcom G6 System; § Bolus delivery from the Tandem t:slim mobile app requires a compatible smartphone model and operating system, software version 7.8.1 onwards on the t:slim X2 insulin pump and additional training; || Smart device sold separately. To view a list of compatible devices, visit amsldiabetes.com.au/mobile-compatibility.
References: 1 Beck RW, et al. JAMA. 2017;317(4):371-378; 2 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374; 3 Martens T, et al. JAMA. 2021;325(22):2262-2272; 4 Laffel LM, et al. JAMA. 2020;323(23):2388-2396; 5 Welsh JB, et al. J Diabetes Sci Technol. 2024;18(1):143-7.
© 2025 Tandem Diabetes Care, Inc. All rights reserved. Tandem Diabetes Care, Basal-IQ, Control-IQ, and t:slim X2 are registered trademarks or trademarks of Tandem Diabetes Care, Inc., in the United States and other countries. ©2025 Dexcom, Inc. All rights reserved. Dexcom, Dexcom G6, Dexcom G7, Dexcom ONE+ are registered trademarks of Dexcom, Inc. in the United States and other countries. Australasian Medical and Scientific Limited is a Dexcom company.
MAT-6989